No image published for this recall

No image published for this recall

Teva-indomethacin: out of specification

Official notice

18 Feb 2026

Last checked

18 Feb 2026

Medium riskHealth Canada

An official Health Canada notice concerns Teva-indomethacin: out of specification. The assay may be out of specification in the affected lots. Published 2026-02-18.

What to do now

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.

Recall number

81621

Official notice

2026-02-18

The hazard

The assay may be out of specification in the affected lots.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Lots

100072497, 100072498 & 100072499

Other

RA RA-81621

Recall Numbers

81621

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Product Name - Teva-Indomethacin, Lot number - 100072497, 100072498 & 100072499

Risk / hazard

The assay may be out of specification in the affected lots.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada · Ontario

Company & contacts

Manufacturer

the recalling firm if you have any questions about the recall

Phone

Not provided

Brand: Teva-indomethacin. Contact: the recalling firm if you have any questions about the recall.

Source & status

Source

Health Canada

Tier

beta

Category

HEALTH

Classification

Type II

App estimate

medium

Recall details

Recall number

81621

Classification

Type II

Source tier

beta

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

CA
No image published for this recall

Remifentanil hydrochloride for injection; out of specification (assay & impurity)

Medium riskHealth Canada26 Jun 2026
CA
No image published for this recall

Pms-busulfan 6mg ml: impurity could be out of specification

Low riskHealth Canada29 Apr 2026
CA
No image published for this recall

Suvexx: the assay is out of specification in the affected lot.

Low riskHealth Canada20 Apr 2026

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 18 Feb 2026. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.